Initiator Pharma A/S

SSE:INIT.ST

8.08 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

20232022202120202019201820172016
Operating Activities:
Net Income -27.707-44.132-24.244-10.531-9.339-12.611-9.561-0.887
Depreciation & Amortization 000.0110.0260.0870.0880.0840.012
Deferred Income Tax 00000000
Stock Based Compensation 00000000
Change In Working Capital 4.5598.787-11.4070.463-1.072-2.7012.4490.703
Accounts Receivables 00.013-0.0160-0.002-0.1250.049-0.347
Inventory 00000000
Accounts Payables 00000000
Other Working Capital 0.0058.774-11.3910.463-1.070.00100
Other Non Cash Items 0.0012.6441.5431.9781.7711.642-0.756-0.006
Operating Cash Flow -17.648-32.701-34.097-8.064-8.553-13.582-7.784-0.178
Investing Activities:
Investments In Property Plant And Equipment 000000-0.132-0.177
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 0-0.0170000-0.132-0.168
Investing Cash Flow 0-0.0170000-0.132-0.177
Financing Activities:
Debt Repayment -0.0030-0.01300000
Common Stock Issued 0.01237.48441.64814.0071.62420.90414.9170.521
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 2.8590.03713.290.0140.00120.90414.9170.782
Financing Cash Flow 2.87137.48454.93814.0071.62520.90414.9170.521
Other Information:
Effect Of Forex Changes On Cash 0000000.0010.355
Net Change In Cash -14.7764.76620.8425.943-6.9297.3227.0020.521
Cash At End Of Period 24.33639.11234.34613.5047.56214.4917.1690.167